Isodiol International Inc

Isodiol International Inc. signs Definitive Licensing Agreement with Canopy Growth Corporation for Canadian and International Distribution

Isodiol International Inc. signs Definitive Licensing Agreement with Canopy Growth Corporation for Canadian and International Distribution

 

 

 Isodiol International Inc

FOREX INVESTORS  PRESS RELEASE  Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).

Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee” and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow.  Licensed products include caffeinated and de-caffeinated product lines as well as Isodiol’s single serve “Pot-O-Coco”.  In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.

“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world.  We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels.  The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.



 Isodiol International Inc

The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation.  While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future.  Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine.  As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.

About Isodiol International Inc.

Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



Buz Investors Greengro Technologies Concludes Successful First Quarter – March 14, 2017) – Greengro Technologies, Inc.

Greengro Technologies, Inc.(GRNH) Signs $17 Million Purchase Contract

Greengro Technologies Signs $17 Million Purchase Contract for PV Solar Glass Hydroponic Vegetable Greenhouse
Buz Investors Greengro Technologies Concludes Successful First Quarter – March 14, 2017) – Greengro Technologies, Inc.

FOREX INVESTORS   PRESS RELEASE  Greengro Technologies, Inc.(GRNH), one of the fastest growing companies in the emerging indoor agriculture technology industry, today announced that its majority-owned subsidiary Biodynamics, LLC, Akron, Ohio, has been awarded a contract to sell a branded photovoltaic (PV) solar glass hydroponic vegetable greenhouse as part of a $17 million purchase agreement with GH Farms Group, LLC, an Ohio-based greenhouse company.
Under terms of the agreement, Biodynamics will construct a 254,528 sq. ft. PV solar glass hydroponic vegetable greenhouse for GH Farms Group, with construction expected to start in the third quarter of 2018. The project, incorporating Biodynamics’ industry-leading fully automated off-grid greenhouse technology, will cultivate vegetables hydroponically using Biodynamics’ proprietary controlled environment agriculture (CEA) growing systems and techniques.

“We welcome this opportunity to show that our greenhouses are the market’s best – climate-controlled by a positive pressure HVAC system with water and nutrients managed by an IBM Watson AI computer-automated irrigation system,” noted Trisha Madden, CEO of Biodynamics.



Greengro Technologies

 

“We are very pleased to be moving forward with the vegetable-growing sector of our operations,” said Greengro Technologies CEO James Haas. “Our indoor growing technologies have enormous potential across many types of agriculture applications and we expect to become a major competitor in the space.”

Haas noted that Biodynamics’ unique PV solar glass hydroponic greenhouses are an environmentally beneficial and economically lucrative alternative to traditional farming methods that are stressful to the environment and present growers with significant operational and economic challenges.

Separately, Greengro Technologies announced progress with a $25 million project signed in February 2017 with Global Renewable Resources LLC (GRR), Shaker Heights, Ohio. The City of Warren, Ohio’s Mayor William D. Franklin recently committed the needed land to develop the project. “The backers of this project are not shy about their intentions to confront the disturbing trend of population decline in this region,” said Franklin.  “With careful attention paid to the realities of our current commercial environment, this project helps to inject new opportunities in the community because it has the capability to create exceptional produce and services for a growing market. I support this development and look forward to working with GRR to realize the full potential of this project through land assembly and other supports.”

GRR is a startup specializing in sustainable technologies and renewable energy. After securing the land for the greenhouse project from the City of Warren, GRR management is currently working on completing the project’s capital raise, expected to be closed by the end of second quarter of 2018.

In other news, Greengro has completed all project planning for the Foodraiser Project in Columbus, Ohio as contracted, and is currently waiting for Foodraiser management to respond with a timeline for the completion of land acquisition and financing.

According to a 2016 report published by Markets and Markets Research, the indoor farming market is expected to grow at a CAGR of 24.8% from 2016 and reach USD $5.80 billion by 2022.  Based on detailed analysis of all factors impacting the vertical farming market, expected growth will reach the highest CAGR between 2016 and 2022.

CEA

Controlled Environment Agriculture (CEA) is an advanced and intensive form of hydroponic agriculture. Plants are grown within a controlled environment so that best horticultural practices can be implemented.  CEA structures optimize the use of resources such as water, energy, space, capital and labor. CEA itself is a combination of engineering, plant science and computer managed greenhouse control technologies used to optimize plant growing systems, plant quality, and production efficiency. CEA systems regulate components such as the temperature, lighting, and CO2, which allow for stable control of the plant environment. CEA also provides separate control of the root-zone environment. CEA provides secure, healthy, and cost-effective year-round production of many premium edible, ornamental, and high-value plant species.  CEA agricultural technology enables growers to control a crop’s environment to the desired conditions. CEA technologies include greenhouse, hydroponics, aquaculture and aquaponics. Controlled variables include temperature, humidity, pH balance and nutrient analysis.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



Buz Investors Chinese producer price index climbed Primarily reflecting a jump in energy prices, the Labor Department released a report on Tuesday showing that U.S. producer prices rose by more than expected in the month of January.

Fed’s Beige Book sees increasing signs of labor shortages, higher wages

|Chart | Calendar   | TRADE NOW | USD

United States Redbook Index | Data | Chart | Calendar

BUZ INVESTORS labor shortages  Redbook Index in the United States increased by 1.80 percent in the week ending May 27 of 2017 over the same week in the previous year. Redbook Index in the United States averaged 2.23 percent from 2005 until 2017, reaching an all time high of 7.60 percent in March of 2005 and a record low of -5.80 percent in July of 2009.



labor shortages

United States Redbook Index

The Johnson Redbook Index measures the growth in the U.S. retail sales. The index is based on the sales data of around 9,000 large general merchandise retailers representing over 80 percent of the equivalent ‘official’ retail sales series collected and published by the US Department of Commerce. This page provides the latest reported value for – United States Redbook Index – plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news. United States Redbook Index – actual data, historical chart and calendar of releases – was last updated on May of 2017.

 

Actual Previous Highest Lowest Dates Unit Frequency
1.80 2.00 7.60 -5.80 2005 – 2017 percent Weekly
NSA

Like up on FACEBOOK


logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)




BUZ INVESTORS Definitive Agreement Tetra Bio-Pharma Inc. (“Tetra” orCN)announced today

Tetra Bio-Pharma Inc. (TBPMF) Signs Definitive Agreement for Two Products

|Chart | Calendar   | TRADE NOW | CANNABIS

Tetra Bio-Pharma Signs Definitive Agreement for Two Products with Panag Pharma

BUZ INVESTORS PRESS RELEaSE  Definitive Agreement   Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announced today it has signed a definitive agreement with Panag Pharma Inc. for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation. Combined total market potential of both products in the USA in 2014 is estimated over US$5.5 billion. The recent press release on May 17th for the filing of a patent in ocular disease combined with the patents from Panag in the ocular space make this agreement very lucrative.

Per the definitive agreement, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra will have a right of first negotiation for future cannabinoid-based products.

Tetra will work in close collaboration with Panag’s team of experts to ensure a rapid and successful development leading to marketing authorization. Panag will continue work in the development of novel products for unmet medical need and Tetra will take the lead in commercializing these novel drug products.

“We are very pleased to announce this partnership with Panag as we work towards building an innovative product pipeline focused on cannabis,” said Andre Rancourt, CEO of Tetra Bio-Pharma. “Tetra is committed to generating revenues in 2017 by launching several products in the retail market through its partnership with Panag.”



Definitive Agreement  

Panag has developed potential new cannabinoid-based therapies for ocular and topical anti-inflammatory and pain markets. The total ocular anti-inflammatory market was estimated at over $3 billion in the USA in 2014 and includes conditions such as post-op inflammation, allergic conjunctivitis and inflammatory dry eye. Panag also developed a cannabinoid topical drug product for the local treatment of pain and inflammation. In 2014, the over the counter sales of topical analgesics were estimated at over $2.5 billion according to IMS.

“We will prioritize the development of the ocular therapy as this is a promising innovative product with high medical need and a significant potential financial reward,” said Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma. Tetra has positioned itself to become a leader in topical pain relief.

Corporate Update:

Tetra changed today at the opening of the U.S. markets its OTCQB stock symbol to TBPMF.

The Company issued 501,800 new shares as part as of a service agreement as previously announced in a news release on June 20, 2016.

Definitive Agreement  

The Company issued an additional 250,000 new shares as part of a service agreement with MAPH Enterprises, LLC, effective May 8, 2017 to broaden U.S. investor awareness.

About Panag Pharma:

Panag Pharma Inc. is a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. Panag believes that pain relief should be safe, non-addictive and above all; effective. The Panag Pharma team of PhD scientists and medical doctors are among the world’s leading researchers and clinicians in the area of pain treatment and management. They bring a combined experience of over 100 years in research and clinical care of people dealing with chronic pain and inflammatory conditions. Panag’s current pipeline of pain relief products include formulations for the topical application to the skin, the eye and other mucous membranes. Recently approved by Health Canada and currently undergoing clinical trials, Panag Pharma’s Topical AOTC provides a new approach to the treatment of chronic pain and inflammation.

About Tetra Bio-Pharma:

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325411    SIC: 3741
Compare: NAS:(NTRP), OTCPK:(TBQBF), NAS:(EIGR), NAS:(CASI), OTCPK:(AMEUF), NAS:(IPCI,) NAS:(KMPH), NAS(:(CTIC), NAS:(FLKS), NAS:(GLMD), NAS:(TCON), NAS:(CTRV), NAS:(PULM), NAS:(ZSAN), OTCPK:(ANTB), OTCPK:(CNNRF), NAS:(CUR), NAS:(CFRX), NAS:(TTNP), NAS:(BLPH) » details
Traded in other countries: TBP.Canada, JAM1.Germany,
Headquarter Location: Canada

Tetra Bio Pharma Inc, formerly GrowPros Cannabis Ventures Inc provides medical marijuana consultation and also engaged in the production and sale of medical marijuana.

Mazorro Resources Inc. was incorporated under the Canada Business Corporations Act on May 17, 2007. It is an exploration stage junior mining company engaged in the identification, acquisition, evaluation and exploration of mineral properties in Mexico.

 

Like up on FACEBOOK Definitive Agreement


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Buz Investors Canabo Medical Inc. Opens New Clinic i- Canabo Medical Inc. (TSX VENTURE: CMM) (OTCQB: CAMDF) ("Canabo" or the "Company") is pleased to announce it has opened a clinic in Chilliwack, British Columbia

Canabo Signs Collaborative Agreement to Jointly Develop Specifically Targeted Cannabinoid Treatments with Terra Life Sciences Inc.

Canabo Signs Collaborative Agreement to Jointly Develop Specifically Targeted Cannabinoid Treatments with Terra Life Sciences Inc.

 

BUZ INVESTORS PRESS RELEASE Canabo Signs Collaborative Agreement Canabo Medical Inc. (TSX VENTURE: <span data-recalc-dims=(CMM) (OTCQB:" width="300" height="300" srcset="https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/03/iszoKIoU.png?resize=300%2C300 300w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/03/iszoKIoU.png?resize=150%2C150 150w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/03/iszoKIoU.png?resize=65%2C65 65w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/03/iszoKIoU.png?w=450 450w" sizes="(max-width: 300px) 100vw, 300px" />

BUZ INVESTORS PRESS RELEASE  Canabo Signs Collaborative Agreement Canabo Medical Inc. (TSX VENTURE: (CMM) (OTCQB: (CAMDF) (“Canabo” or the “Company”) is pleased to announce it has entered into a collaborative agreement (“Agreement”) with Terra Life Sciences Inc. (“Terra Life”) of Calgary, Alberta to jointly work on the R&D and clinical application of cannabinoid-based treatments targeted to specific conditions. The intended outcome of the agreement will be to develop new cannabinoid-based formulations to target specific medical conditions and illnesses such as chronic pain or anxiety. In addition, the agreement specifies both parties will conduct joint medical research and testing, and share future revenues from any new medical formulations and IP developed.

Terra Life Sciences is a holding company of a subsidiary operating as Olds SoftGels Inc. The Terra Life Sciences group owns and operates two pharma-grade facilities with capabilities to manufacture pharmaceuticals, over the counter (“OTC”) and premium grade nutraceuticals. Terra Life currently manufactures over 100 different products and has a manufacturing capacity of over 2.5 billion softgels per year, with access to an R&D department that includes 8 PhDs on staff. These facilities are licensed by Health Canada and are fully GMP compliant.

Key aspects of the Agreement include both companies working jointly to identify, develop and conduct medical research on new cannabinoid formulations designed to assist patients with specific conditions such as pain management and anxiety. The Agreement also provides for revenue sharing on any licensing revenues resulting from any newly developed products. The Agreement covers the following key stages.




 

Canabo Signs Collaborative Agreement

>>>TRADE NOW<<<

Identifying opportunities for condition treatments – review of Canabo’s patient observational data to identify conditions and illnesses that show promise for successful replacement of existing therapies.

R&D – chemical, genetic and extraction lab work lead by Terra Life to develop cannabinoid formulations uniquely targeted to specific conditions with feedback and input from the Canabo physician network.

QA/QC production and dosage control – Terra Life will oversee the processing of targeted cannabinoid plants, cannabis oils, active ingredients and manage quality assurance testing and processing into delivery mechanisms, such as softgel capsules, to provide precise dosage control.

Observational data collection – utilizing Canabo’s network of physicians and patients, Canabo will observe patient response and treatment efficacy for both primary conditions and side effects and where appropriate, Canabo physicians will publish the observational data.

Product formulation adjustment – based on observational research data, additional R&D work on cannabis formulation development will be led by Terra Life.

Clinical trial testing – jointly, and including participation from independent physicians and researchers, Canabo and Terra Life intend to conduct double-blind, placebo controlled clinical trials pertaining to each newly developed cannabinoid formulation. It is anticipated all clinical trials will be physician peer-reviewed and published in medical journals.

Dr. Neil Smith, Executive Chairman of Canabo Medical Inc. stated, “Today’s announcement represents a significant goal for Canabo, using best-practice R&D to target specific conditions, achieving high QA/QC and dosage control, and evidence based research. This future for cannabinoid treatments is precisely what patients and prescribing physicians want.”

Dr. Anil Jain, President and CEO of Terra Life Sciences Inc. added, “The medical cannabis industry is in its infancy. To grow beyond the current anecdotal practices the industry needs innovative science, controlled production and evidence-based research. This collaboration will elevate the industry with Canabo and Terra Life Sciences at the forefront.”

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Canabo
Canabo wholly owns and operates Cannabinoid Medical Clinics, or CMClinics, Canada’s most respected and largest referral-only clinics for medical cannabis. Since beginning operations in 2014, Canabo now has clinic locations in Toronto, Barrie, St. Catharine’s, Burlington, Stoney Creek, Ottawa, Hamilton, Halifax, St. John’s, Moncton, Kingston, Edmonton, Calgary and Chilliwack.

About Terra Life Sciences
Terra Life Sciences is a holding company of a subsidiary operating as Olds SoftGels Inc. The Terra Life Sciences Group (“The Group”) owns and operates two pharma-grade facilities with capabilities to manufacture highly potent pharmaceuticals, Over the Counter (“OTC”) and premium grade nutraceuticals, for both domestic and international markets. One of these facilities has been operating for more than thirty years. These facilities are licensed by Health Canada and fully GMP compliant.

The Group is the process of securing its ACMPR license to enable the extraction of Active Pharmaceutical Ingredients from Cannabis and to manufacture and sell pharma-grade doses in various delivery systems. The Group offers excellence in manufacturing doses in various delivery systems such as softgels, liquids, topical, sprays and liposomes, with capabilities for quick release, sustained release and targeted release of medicine. The Group is focused on scientific research and collaboration, and has plans to participate in clinical trials to fully explore the potential of cannabis for patient health, and to provide evidence-based products for the comfort of health practitioners.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Japanese manufacturing PMI climbed in September

Japan’s Deflated Economy Shows Signs of Life in Q1

Japan’s Deflated Economy Shows Signs of Life in Q1

Japanese manufacturing PMI climbed in September

BUZ INVESTORS Japan’s Deflated Economy Japan’s modest recovery gathered pace in the first quarter, fueled by higher corporate profits and government spending. At the same time, weak earnings growth and declining consumption have made improvements tepid and difficult to predict. PMI data from Markit confirmed last week that Japan’s Nikkei composite output index registered its strongest three-month expansion in over three years. Markit said the PMI data were consistent with nominal GDP expanding at an annualized 2.5% in the first quarter. By comparison, Japan’s economy grew just 1.2% annually in the fourth quarter. Compared to the third quarter, the economy expanded just



OTHER STORIES BUZ TRADERS FOLLOW

Japan’s Deflated Economy

While Japan’s economy has expanded in each of the last four quarters, growth slowed throughout 2016. A solid start to 2017 would alleviate concerns that the economy was stagnating.

Perhaps more importantly, inflationary pressures returned in the first quarter, with core consumer prices rising at the fastest clip in nearly two years. Core inflation advanced 0.2% in the 12 months through February, the highest since April 2015.

Core inflation in Tokyo, available one month before nationwide data, declined 0.4% in March from a year earlier.

Inflation is gradually resurfacing after a year of negative price growth undermined government efforts to stimulate the economy. A weaker yen and rebounding energy prices have been largely responsible for the recent pickup in consumer prices. However, the Bank of Japan (BOJ) has acknowledged that “inflation expectations have remained in a weakening phase.”

Like up on FACEBOOK


Ebates Coupons and Cash Back



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD)




Buz Investors Silver Spruce Signs Purchase Agreement - Bridgewater, NS - (TSXVSE:SSE) – Silver Spruce Resources Inc. ("Silver Spruce" or the "Company") is pleased to announce it has entered a Purchase Agreement with Cedar Forrest, LLC (the “Vendor”) to acquire 100% ownership of 70.84 acres of patented claims covering the past-producing Kay Mine

Silver Spruce Signs Purchase Agreement for 100% interest in Past-Producing Kay Mine in Arizona, USA

Silver Spruce Signs Purchase Agreement for 100% interest in Past-Producing Kay Mine in Arizona, USA

Buz Investors Silver Spruce Signs Purchase Agreement - Bridgewater, NS - <span data-recalc-dims=(TSXVSE:SSE) – Silver Spruce Resources Inc. ("Silver Spruce" or the "Company") is pleased to announce it has entered a Purchase Agreement with Cedar Forrest, LLC (the “Vendor”) to acquire 100% ownership of 70.84 acres of patented claims covering the past-producing Kay Mine" width="219" height="219" srcset="https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/03/Silver-Spruce-Small.jpg?resize=300%2C300 300w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/03/Silver-Spruce-Small.jpg?resize=150%2C150 150w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/03/Silver-Spruce-Small.jpg?resize=65%2C65 65w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/03/Silver-Spruce-Small.jpg?w=480 480w" sizes="(max-width: 219px) 100vw, 219px" />

Buz Investors Silver Spruce Signs Purchase Agreement – Bridgewater, NS – (TSXVSE:SSE) – Silver Spruce Resources Inc. (“Silver Spruce” or the “Company”) is pleased to announce it has entered a Purchase Agreement with Cedar Forrest, LLC (the “Vendor”) to acquire 100% ownership of 70.84 acres of patented claims covering the past-producing Kay Mine, located in Yavapai county, Arizona, roughly 50 miles north of Phoenix. The Kay Copper Company and others produced Au-Ag-Cu-Pb-Zn ore on the property intermittently from 1916 until 1956. Exploration conducted from 1972 to 1982 by Exxon Minerals Company, a subsidiary of Exxon Petroleum, indicates that substantial additional mineralization exists down dip and potentially along strike from the previously producing mineral deposits.



OTHER STORIES BUZ TRADERS SHARE

Silver Spruce Signs Purchase Agreement

Known mineralization occurs in two zones of massive sulfide, the North and South Zones, extending from the surface to at least 2100 feet in depth. Mineralization is open at depth. A November 1982 internal Exxon Minerals Company report by M. L. Fellows stated that the deposit contains a resource of “Proven and Probable ore” with a tonnage of 6.4 million short tons grading an estimated 2.2% copper, 3.03% zinc, 1.6 ounces per ton silver and 0.082 ounces per ton gold. The estimate was made using assay data from historic mine level plans and Exxon drill hole intercepts. Exxon’s use of the word “ore” is not to be construed in the strict sense.. After examining mine assay level plans and Exxon drill hold data, Silver Spruce has concluded that “Indicated Mineral Resource” is the appropriate term for Exxon’s historical estimate. Additional drilling is needed to verify this estimate. The Qualified Person for Silver Spruce has not conducted sufficient work to definitively classify Exxon’s resource estimate to be compliant with NI-43-101 resource definitions.  The issuer is not treating the historical estimate as current mineral resources or mineral reserves. Exxon also reported the deposits to be open down dip, with significant additional potential for the discovery of new deposits.

We are excited to have this opportunity to purchase, explore and develop resources at the Kay Mine property, located near Black Canyon City, Arizona, a very mining supportive community. We intend to apply geophysical methods that did not yet exist in the early 1980’s and to drill  the Historic Estimate outlined by Exxon,” stated Karl J. Boltz, President and CEO.

Kay Mine History

The Kay Mine was discovered prior to 1900 and was mined on a small scale up to 1916, producing some 700 tons of ore, 470 tons of which ran 9.1% copper, 1.06 ounces per ton silver and 0.072 ounces per ton gold. It was during this period that the No. 1 shaft was sunk. The major underground development of the mine took place between 1918 and 1923 when the No.1 shaft was deepened and the 1200 foot vertical No. 4 shaft (with an internal winze to 1500 feet) was sunk and several thousand feet of development drifts were driven, but no ore was shipped. The property was acquired for back taxes in the late 1940’s. It was leased in 1949 by the Black Canyon Copper Corporation which shipped 1,000 tons of high grade ore that year.

In 1950, Shattuck-Denn Mining Company and New Jersey Zinc dewatered and rehabilitated the number 4 shaft and conducted surface and underground exploration until 1952. This was the first time since 1929 that the mine was dewatered and made accessible. During this time, 1,571 tons of ore were shipped from underground workings and from dump material, the total averaging 5.67% Cu, 0.98 ounces per ton Ag and 0.059 ounces per ton Au.

In 1955, Republic Metals Company shipped a few hundred tons from above the 350’ level in the number 4 shaft. About this time a cave-in destroyed the pump station and the mine was allowed to flood. The underground workings have been inaccessible ever since and no underground production or development has been done since then. Only about 4,000 tons of ore was documented to have been produced at the Kay Mine property, largely due to the intermittent production in between periods of litigation.

The property was acquired in 1972 by Exxon Minerals Company. Between 1972 and 1982 Exxon conducted an extensive exploration program consisting of geologic mapping, sampling, ground and airborne geophysics and drilling. Exxon drilled 23 core and rotary holes totaling 26,554 feet. Exxon expended roughly $1,500,000 during this time.

Terms of Purchase

Upon execution of the Purchase Agreement to acquire 100% interest in the patented claims, free of any royalties, Silver Spruce has paid a non-refundable deposit of US $50,000 to the Vendor.

The Company will pay US $450,000 cash to the Vendor within 75 days.

The Vendor will carry a two-year, 6%, convertible debenture for the principle amount of US $477,000 which is the balance of the total purchase price.

The interest on the debenture will be paid monthly, and the principle may be converted into common shares of the Company at an exercise price of CAD $0.225 per common share, at any time during the term of the debenture.

This acquisition is subject to Exchange acceptance.

A finder’s fee will be paid to a party that is Arm’s Length to Silver Spruce and to the Vendor, subject to TSXVSE approval.

The Finder is Rift Exploration LLC, and will be paid 7.5% of the purchase price, paid in common shares of the Company.

Due Diligence

The Company has rapidly and efficiently conducted due diligence activities on the project, since January 30, 2017. These activities included a site visit, an appraisal of the fee simple surface land value, a fee simple surface title opinion, an extensive mining title search and analysis of the mining rights held with the patented claims titles and a legal opinion of the mineral title rights by a prominent mining attorney in Arizona.

Qualified Person

Mr. Leonard J. Karr, professional geologist and a Qualified Person, under TSX guidelines, is the author of the Company’s NI 43-101 report on the Pino de Plata project, dated 7 July 2015, and is responsible for the technical content of this press release.

About Silver Spruce Resources Inc.

Silver Spruce Resources Inc. is a well-positioned Canadian junior exploration company pursuing development of the Pino De Plata and the Encino De Oro epithermal silver/ base metal/ gold projects located in the prolific Sierra Madre Occidental region of western Chihuahua State in Mexico. Silver Spruce also retains a portfolio of uranium and rare earth element properties in Labrador.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The company seeks Safe Harbour.


Ebates Coupons and Cash Back



Commodities ( Gold ) ( Silver ) ( Lithium )




SinglePoint, Inc. Signs LOI to Invest $800K in Jacksam Corp., Creator of Revolutionary Cannabis Technology

SinglePoint, Inc. Signs LOI to Invest $800K in Jacksam Corp., Creator of Revolutionary Cannabis Technology

Buz Investors SinglePoint, Inc. Signs LOI SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, is entering an exciting niche of the cannabis industry through a Letter of Intent (“LOI”) to acquire an interest in Jacksam Corp

Buz Investors SinglePoint, Inc. Signs LOI SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, is entering an exciting niche of the cannabis industry through a Letter of Intent (“LOI”) to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry.

Convectium is the creator of the world’s first oil filling machine focused on the cannabis industry that is capable of filling cartridges or disposable vape pens for wholesale distribution to dispensaries. The company’s 710Shark and 710Seal system can fill and package up 100+ cartridges or disposable vape pens in 30 seconds, making it the fastest filling and sealing system of its kind.



OTHER STORIES BUZ TRADERS FOLLOW

SinglePoint, Inc. Signs LOI

Convectium operates a B2B equipment division in addition to its legacy B2C products. The proprietary equipment is solely distributed by EquipCanna.com, the Convectium B2B brand. Based on its market position and increasing demand for its products and services, Convectium forecasts revenues for 2017 at $3.5 million, an increase of 150% compared to revenue of $1.4 million for 2016.

Convectium ships its consumer brands to over 52 countries. The company’s line of B2C brands include BlackoutX as well as HazeSticks, inspired by the Jimi Hendrix Cannabis Collection.

“To say we are excited about this opportunity is an understatement,” states SinglePoint CEO, Greg Lambrecht. “Convectium’s 710Shark and 710Seal system is incredible, and its capabilities are unmatched. After looking at hundreds of cannabis companies, finding an acquisition opportunity like we have found in Convecitum adds a new dynamic to our endeavors and the cannabis industry as a whole.”

Per the LOI, SinglePoint will pay Jacksam a stock and cash consideration totaling $800,000. The transaction is expected to accelerate SinglePoint’s existing presence in the cannabis industry – established by its SingleSeed subsidiary – while creating another avenue of participation in the “Green Rush” of the multi-billion dollar cannabis industry.

“We are excited to enter into an agreement with SinglePoint, one of the leading and most visionary publicly traded cannabis companies in the market. Paired with our proprietary technology and commitment to the future of the infrastructure of the cannabis industry, Convectium and SinglePoint are creating a unique business dynamic with incredible potential,” says Danny Davis, managing partner at Convectium.

A definitive agreement on the announced transaction is expected no later than May 24, 2017, subject to certain terms and conditions, the completion of due-diligence and obtaining the required consents and regulatory approvals.

About SinglePoint, Inc.

SinglePoint, Inc. is a full-service mobile technology and marketing provider. The company provides solutions that allow its clients to conduct business transactions, accept donations, and engage in targeted communication through mobile devices. SinglePoint products connect small to mid-size companies to their target markets by providing innovative mobile technology at reasonable rates. SinglePoint recognized the strength in acquiring interest in undervalued subsidiaries in other markets, such as Daily Fantasy Sports, to create a diversified holding base.

Connect on social media at: www.facebook.com/SinglePointMobile, www.twitter.com/_SinglePoint_, www.linkedin.com/company/SinglePoint and www.youtube.com/user/SinglePointMobile

For more information visit www.SinglePoint.com.

About Jacksam Corp. dba Convectium

Convectium was founded in October of 2013 and based in South Orange County, California. Convecitum does not touch plants; its branding, packaging and equipment solutions help grow the companies that do. With the industry’s first and only oil filling system, proprietary packaging systems and innovative devices, Convectium represents a commitment to the future of infrastructure in the cannabis industry.

See the 710Shark at work here: https://vimeo.com/169612830

For more information visit www.Convectium.com, www.BlackoutX.com or www.710Shark.com.



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




China's Largest Media Platform Signs Historic Agreement to Fund Imagination Park Films

China’s Largest Media Platform Signs Historic Agreement to Fund Imagination Park Films

China’s Largest Media Platform Signs Historic Agreement to Fund Imagination Park Films

 

 

China's Largest Media Platform Signs Historic Agreement to Fund Imagination Park Films

Vancouver, BC / March 9, 2017 – Imagination Park Entertainment Inc. (CSE: IP) (OTC: IPNFF) (“Imagination Park” or the “Company”) is pleased to announce that it has entered into an agreement with China’s largest media content provider Ohmore Media Inc. to finance up to 12 short films including 360 degree Virtual Reality content, for premiere release on the largest new media platform in China.

Ohmore Media, partner of the Ergeng Network, achieves over 50 billion page views per month with more than 200 distribution channels. As one of the largest global content sites, Ohmore Media has agreed to finance up to 12 Imagination Park’s Virtual Reality titles and short films. The films will be in the popular science fiction/fantasy genre with several to be produced in China.  Additionally, Ohmore Media Inc. maintains the right of first refusal to finance any feature films or TV series, which directly result from these original short film projects.



OTHER STORIES BUZ TRADERS FOLLOW

China’s Largest Media Platform

Director Yas Taalat stated   “As original content providers, this agreement launches Imagination Park as a highly regarded global VR & short film company. Securing Ohmore as our partner in China, we can attract hundreds of millions viewers for our unique content as well as having the opportunity to convert these projects into full feature films or TV series with a powerful partner”.

Tim Marlowe, President of Imagination Park added   “The type of original content we produce is highly stylized and has a ready-made global audience.  With our licensing deal with Ohmore and this new production agreement, I think we’ve found an international partner in the hottest and biggest market in the world to deliver our content to a market that loves this content and generate recurring advertising revenue”.

This agreement was signed in Vancouver, BC by Imagination Park’s CEO Gabriel Napora.

About Imagination Park

Imagination Park is an emerging digital content production company, working with talented filmmakers around the world to bring conventional as well as virtual reality content to life.

For more information or to explore working with Imagination Park, please call 604.446.7325, email info@imaginationpark.com , or visit www.imaginationpark.com .



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )